229 related articles for article (PubMed ID: 36801811)
21. Nailfold videocapillaroscopy alterations in dermatomyositis, antisynthetase syndrome, overlap myositis, and immune-mediated necrotizing myopathy.
Soubrier C; Seguier J; Di Costanzo MP; Ebbo M; Bernit E; Jean E; Veit V; Swiader L; Salort-Campana E; Attarian S; De Paula AM; Kaplanski G; Durand JM; Harlé JR; Schleinitz N
Clin Rheumatol; 2019 Dec; 38(12):3451-3458. PubMed ID: 31440919
[TBL] [Abstract][Full Text] [Related]
22. Where are we moving in the classification of idiopathic inflammatory myopathies?
Tanboon J; Uruha A; Stenzel W; Nishino I
Curr Opin Neurol; 2020 Oct; 33(5):590-603. PubMed ID: 32852298
[TBL] [Abstract][Full Text] [Related]
23. Autoimmune muscle disease.
Mammen A
Handb Clin Neurol; 2016; 133():467-84. PubMed ID: 27112692
[TBL] [Abstract][Full Text] [Related]
24. Distinct interferon signatures stratify inflammatory and dysimmune myopathies.
Rigolet M; Hou C; Baba Amer Y; Aouizerate J; Periou B; Gherardi RK; Lafuste P; Authier FJ
RMD Open; 2019; 5(1):e000811. PubMed ID: 30886734
[TBL] [Abstract][Full Text] [Related]
25. cDNA microarrays reveal distinct gene expression clusters in idiopathic inflammatory myopathies.
Zhou X; Dimachkie MM; Xiong M; Tan FK; Arnett FC
Med Sci Monit; 2004 Jul; 10(7):BR191-7. PubMed ID: 15232492
[TBL] [Abstract][Full Text] [Related]
26. RIG-I expression in perifascicular myofibers is a reliable biomarker of dermatomyositis.
Suárez-Calvet X; Gallardo E; Pinal-Fernandez I; De Luna N; Lleixà C; Díaz-Manera J; Rojas-García R; Castellví I; Martínez MA; Grau JM; Selva-O'Callaghan A; Illa I
Arthritis Res Ther; 2017 Jul; 19(1):174. PubMed ID: 28738907
[TBL] [Abstract][Full Text] [Related]
27. The host defense peptide LL-37 a possible inducer of the type I interferon system in patients with polymyositis and dermatomyositis.
Lu X; Tang Q; Lindh M; Dastmalchi M; Alexanderson H; Popovic Silwerfeldt K; Agerberth B; Lundberg IE; Wick C
J Autoimmun; 2017 Mar; 78():46-56. PubMed ID: 28012697
[TBL] [Abstract][Full Text] [Related]
28. Activation of cGAS-STING pathway - A possible cause of myofiber atrophy/necrosis in dermatomyositis and immune-mediated necrotizing myopathy.
Zhou M; Cheng X; Zhu W; Jiang J; Zhu S; Wu X; Liu M; Fang Q
J Clin Lab Anal; 2022 Oct; 36(10):e24631. PubMed ID: 36030554
[TBL] [Abstract][Full Text] [Related]
29. Morphologic and Molecular Patterns of Polymyositis With Mitochondrial Pathology and Inclusion Body Myositis.
Kleefeld F; Uruha A; Schänzer A; Nishimura A; Roos A; Schneider U; Goebel HH; Schuelke M; Hahn K; Preusse C; Stenzel W
Neurology; 2022 Nov; 99(20):e2212-e2222. PubMed ID: 36195449
[TBL] [Abstract][Full Text] [Related]
30. SIGLEC1 enables straightforward assessment of type I interferon activity in idiopathic inflammatory myopathies.
Graf M; von Stuckrad SL; Uruha A; Klotsche J; Zorn-Pauly L; Unterwalder N; Buttgereit T; Krusche M; Meisel C; Burmester GR; Hiepe F; Biesen R; Kallinich T; Stenzel W; Schneider U; Rose T
RMD Open; 2022 Feb; 8(1):. PubMed ID: 35177553
[TBL] [Abstract][Full Text] [Related]
31. Immune Checkpoint Inhibitor-Associated Myositis: A Distinct Form of Inflammatory Myopathy.
Saygin D; Ghosh N; Reid P
J Clin Rheumatol; 2022 Oct; 28(7):367-373. PubMed ID: 35696731
[TBL] [Abstract][Full Text] [Related]
32. Dermatomyositis unleashed by immune checkpoint inhibitors. Three additional cases and a review of the literature.
Guerra NL; Matas-García A; Serra-García L; Morgado-Carrasco D; Padrosa J; Aldecoa I; Duque Y; Casal-Dominguez M; Muñoz-Braceras S; Aranega R; Moreno-Lozano P; Cantó-Santos J; Garrabou G; Ruiz-Ortiz E; Trallero-Araguas E; Selva-O'Callaghan A; Grau JM; Puig S; Torres-Ruiz J; Mammen AL; Fernandez IP; Milisenda JC
Autoimmun Rev; 2023 Aug; 22(8):103375. PubMed ID: 37321468
[TBL] [Abstract][Full Text] [Related]
33. [The effect of interferon-gamma on skeletal muscle cell biology].
Hou C; Baba-Amer Y; Bencze M; Relaix F; Jérôme Authier F
Med Sci (Paris); 2018 Nov; 34 Hors série n°2():35-38. PubMed ID: 30418144
[TBL] [Abstract][Full Text] [Related]
34. Incidence and Distinct Features of Immune Checkpoint Inhibitor-Related Myositis From Idiopathic Inflammatory Myositis: A Single-Center Experience With Systematic Literature Review and Meta-Analysis.
Hamada N; Maeda A; Takase-Minegishi K; Kirino Y; Sugiyama Y; Namkoong H; Horita N; Yoshimi R; Nakajima H;
Front Immunol; 2021; 12():803410. PubMed ID: 34938300
[TBL] [Abstract][Full Text] [Related]
35. Myxovirus resistance protein A (MxA) expression in myositides: Sarcoplasmic expression is common in both dermatomyositis and lupus myositis.
Xing C; Trivedi J; Bitencourt N; Burns DK; Reisch JS; Cai C
Muscle Nerve; 2024 May; 69(5):548-555. PubMed ID: 38372203
[TBL] [Abstract][Full Text] [Related]
36. The pattern of MHC class I expression in muscle biopsies from patients with myositis and other neuromuscular disorders.
Milisenda JC; Pinal-Fernandez I; Lloyd TE; Grau-Junyent JM; Christopher-Stine L; Corse AM; Mammen AL
Rheumatology (Oxford); 2023 Sep; 62(9):3156-3160. PubMed ID: 36707996
[TBL] [Abstract][Full Text] [Related]
37. Muscular and extramuscular clinical features of patients with anti-PM/Scl autoantibodies.
De Lorenzo R; Pinal-Fernandez I; Huang W; Albayda J; Tiniakou E; Johnson C; Milisenda JC; Casal-Dominguez M; Corse AM; Danoff SK; Christopher-Stine L; Paik JJ; Mammen AL
Neurology; 2018 Jun; 90(23):e2068-e2076. PubMed ID: 29728522
[TBL] [Abstract][Full Text] [Related]
38. Autoantibodies: Pathogenic or epiphenomenon.
Galindo-Feria AS; Wang G; Lundberg IE
Best Pract Res Clin Rheumatol; 2022 Jun; 36(2):101767. PubMed ID: 35810122
[TBL] [Abstract][Full Text] [Related]
39. Clinical and pathological features of immune-mediated necrotising myopathies in a single-centre muscle biopsy cohort.
Yang H; Tian X; Zhang L; Li W; Liu Q; Jiang W; Peng Q; Wang G; Lu X
BMC Musculoskelet Disord; 2022 May; 23(1):425. PubMed ID: 35524238
[TBL] [Abstract][Full Text] [Related]
40. Perivascular and endomysial macrophages expressing VEGF and CXCL12 promote angiogenesis in anti-HMGCR immune-mediated necrotizing myopathy.
Lia A; Annese T; Fornaro M; Giannini M; D'Abbicco D; Errede M; Lorusso L; Amati A; Tampoia M; Trojano M; Virgintino D; Ribatti D; Serlenga L; Iannone F; Girolamo F
Rheumatology (Oxford); 2022 Aug; 61(8):3448-3460. PubMed ID: 34864921
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
